Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Top Stories

    EU offers China free vaccines as COVID-19 infections surge

    Published by Jessica Weisman-Pitts

    Posted on January 3, 2023

    Featured image for article about Top Stories

    BRUSSELS (Reuters) – The European Union has offered free COVID-19 vaccines to China, the EU executive said on Tuesday, as infections there surged following Beijing’s relaxation of its “zero-COVID” policies.

    China has not responded to the offer yet, a spokesperson for the European Commission told journalists at a regular briefing. He did not specify the amount of vaccines the EU was offering or their manufacturers.

    “In view of the COVID situation in China, (Health) Commissioner Stella Kyriakides has reached out to her Chinese counterparts to offer EU solidarity and support,” he said.

    “This includes public health expertise as well as variant-adapted EU vaccine donations.”

    Asked whether Beijing would accept the EU offer, Chinese Foreign Ministry spokesman Mao Ning sidestepped a direct reply, telling Reuters that China’s vaccination rate and treatment capacity continued to rise and its supplies were “adequate”.

    She said China was open to “strengthening solidarity and cooperation with the international community” to better meet its pandemic challenges, though it could “meet the demand of anyone who wants to be vaccinated”.

    China has so far insisted on using only Chinese-made vaccines – which are of the inactivated virus type and not based on the Western mRNA technology – for its own population.

    Last month, Germany shipped 11,500 BioNTech COVID vaccines to German companies and embassy and consulate locations in China for use by German nationals there.

    A source familiar with the situation said at the time that talks were underway with other European Union governments about getting them to citizens of other nationalities.

    EU health experts were to meet on Tuesday to discuss the COVID situation in member states ahead of another gathering on Wednesday when EU government representatives will weigh a coordinated approach by the bloc to travellers from China.

    (Reporting by Charlotte Van Campenhout in Brussels and Yew Lun Tian in Beijing; Editing by Mark Heinrich)

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe